152 related articles for article (PubMed ID: 5281036)
1. [Long-term results of busulfan treatment].
Comhaire F; Van der Straeten M; Van Hove W; Van Ganse W; Roels H
Acta Tuberc Pneumol Belg; 1970; 61(5):471-80. PubMed ID: 5281036
[No Abstract] [Full Text] [Related]
2. [Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan].
Batzenschlager A; Oberling F; Guerbaoui M; Vetter JM
Arch Anat Pathol (Paris); 1972 Sep; 20(3):291-4. PubMed ID: 4507846
[No Abstract] [Full Text] [Related]
3. [The busulfan lung].
Pintos Fuentes RJ; Reissenweber N
Hoja Tisiol; 1970; 27(1):84-97. PubMed ID: 5291024
[No Abstract] [Full Text] [Related]
4. [Busulfan lung. Pulmonary fibrosis caused by Myleran].
Koch H; Lesch R
Med Welt; 1976 Feb; 27(7):308-11. PubMed ID: 1062649
[No Abstract] [Full Text] [Related]
5. [Pulmonary fibrosis after busulfan therapy].
Jandl H; Franke A; Albrecht G
Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
[TBL] [Abstract][Full Text] [Related]
6. Toxic manifestations of busulfan therapy.
Burns WA; McFarland W; Matthews MJ
Med Ann Dist Columbia; 1971 Sep; 40(9):567-72. PubMed ID: 5315525
[No Abstract] [Full Text] [Related]
7. Busulfan lung-report of a case.
Douay B; Leduc M
Acta Tuberc Pneumol Belg; 1979; 70(3-4):223-7. PubMed ID: 299411
[No Abstract] [Full Text] [Related]
8. Busulfan-induced pulmonary disease. Report of a case and review of the literature.
Burns WA; McFarland W; Matthews MJ
Am Rev Respir Dis; 1970 Mar; 101(3):408-13. PubMed ID: 5263678
[No Abstract] [Full Text] [Related]
9. Busulfan lung.
Pearl M
Am J Dis Child; 1977 Jun; 131(6):650-2. PubMed ID: 266839
[TBL] [Abstract][Full Text] [Related]
10. [Busulfan lung (a case report) (author's transl)].
Sawada S; Takahira Y; Okamoto K; Kobayashi A; Matsuda M; Nakazawa M
Rinsho Hoshasen; 1978 Oct; 23(10):1047-51. PubMed ID: 279729
[No Abstract] [Full Text] [Related]
11. Busulfan lung complicated by pneumocystis carinii and cytomegalovirus infection.
Green GI; Levin RL; Pierce LE; Witorsch P
Med Ann Dist Columbia; 1974 Mar; 43(3):124-8. PubMed ID: 4362467
[No Abstract] [Full Text] [Related]
12. [Clinical heterogeneity of Myleran-induced pneumopathy. Apropos of 2 further cases and review of the literature].
Gyger M; LeGresley LP; Boulianne P; Lacombe M; Lavallée R; Bonny Y; Boileau J; D'Angelo G
Union Med Can; 1977 Nov; 106(11):1522-8. PubMed ID: 270864
[No Abstract] [Full Text] [Related]
13. [A case of pulmonary fibrosis due to misulban].
Douay B; Leduc M; Beaugeard D
Lille Med; 1979 Apr; 24(4):292-4. PubMed ID: 289887
[No Abstract] [Full Text] [Related]
14. [Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
Etcheberry R; Becker P; Delmastro J; Donoso S
Rev Med Chil; 1973 Jan; 101(1):42-6. PubMed ID: 4518637
[No Abstract] [Full Text] [Related]
15. Busulfan lung. Report of two cases and review of the literature.
Podoll LN; Winkler SS
Am J Roentgenol Radium Ther Nucl Med; 1974 Jan; 120(1):151-6. PubMed ID: 4520939
[No Abstract] [Full Text] [Related]
16. [Busulfan-induced pneumopathy].
Massin F; Fur A; Reybet-Degat O; Camus P; Jeannin L
Rev Mal Respir; 1987; 4(1):3-10. PubMed ID: 3473580
[TBL] [Abstract][Full Text] [Related]
17. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
[No Abstract] [Full Text] [Related]
18. Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
Kirschner RH; Esterly JR
Cancer; 1971 May; 27(5):1074-80. PubMed ID: 5281244
[No Abstract] [Full Text] [Related]
19. [Myleran lung in chronic myelosis].
Pietschmann H; Kolarz G
Wien Z Inn Med; 1973; 54(4):150-5. PubMed ID: 4519579
[No Abstract] [Full Text] [Related]
20. Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard.
Hankins DG; Sanders S; MacDonald FM; Drage CW
Chest; 1978 Mar; 73(3):415-6. PubMed ID: 272980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
